Back to BNP Paribas Financial Markets BNP Paribas Financial Markets

BBIO

28 quarters

Position history for BNP Paribas Financial MarketsBNP Paribas Financial Markets's holdings in BridgeBio Pharma, Inc.

Yes. BNP Paribas Financial Markets holds 1,155,442 shares of BBIO (BridgeBio Pharma), worth $86.1M, as of its Q2 2026 13F filing. It reduced the position by 151,734 shares (-11.6%) from Q1 2026. BNP Paribas Financial Markets has held BBIO since Q4 2022, across 15 quarterly 13F filings.

Current Value

$86.1M

Current Shares

1.2M

Total Value Change

+$86M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-11.6%
$86.1M0.0%$74.48
0
2026-Q1
Decreased
1.3M
-17.9%
$97.1M0.0%$74.26
0
2025-Q4
Increased
1.6M
+149.1%
$121.8M0.1%$76.49
49
2025-Q3
Increased
639,264
+45.6%
$33.2M0.0%$51.94
39
2025-Q2
Increased
439,066
+39.5%
$19M0.0%$43.18
38
2025-Q1
Increased
314,702
+1148.3%
$10.9M0.0%$34.57
45
2024-Q4
Decreased
25,210
-33.7%
$691,7620.0%$27.44
0
2024-Q3
Increased
38,039
+186.0%
$968,4730.0%$25.46
40
2024-Q2
Decreased
13,301
-90.4%
$336,9140.0%$25.33
0
2024-Q1
Increased
137,944
+8.4%
$4.3M0.0%$30.92
29
2023-Q4
Decreased
127,260
-14.5%
$5.1M0.0%$40.37
0
2023-Q3
Increased
148,892
+39.1%
$3.9M0.0%$26.37
35
2023-Q2
Decreased
107,052
-6.4%
$1.8M0.0%$17.20
0
2023-Q1
Decreased
114,346
-15.0%
$1.9M0.0%$16.58
0
2022-Q4
New
134,504
-
$1M0.0%$7.62
35
2022-Q3
Exited
0
-100.0%
$00.0%$9.94
0
2022-Q2
Decreased
129,984
-47.4%
$1.2M0.0%$9.08
0
2022-Q1
Increased
246,948
+838.9%
$2.5M0.0%$10.15
42
2021-Q4
Increased
26,302
+14.4%
$438,7170.0%$16.68
27
2021-Q3
Increased
22,982
+262.4%
$1.1M0.0%$46.87
41
2021-Q2
Decreased
6,341
-56.2%
$386,5470.0%$60.96
0
2021-Q1
Increased
14,482
+29.6%
$892,0910.0%$61.60
31
2020-Q4
Decreased
11,179
-34.8%
$794,9390.0%$71.11
0
2020-Q3
Increased
17,135
+97.5%
$642,9050.0%$37.52
39
2020-Q2
Decreased
8,677
-66.3%
$282,9570.0%$32.61
0
2020-Q1
Increased
25,714
+691.9%
$745,7060.0%$29.00
40
2019-Q4
Decreased
3,247
-1.6%
$113,8070.0%$35.05
0
2019-Q3
New
3,298
-
$70,8080.0%$21.47
29

Other major holders of BBIO: Viking Global Investors LP, Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used